Company: INDP
Filing Date: 2025-02-12
Form Type: S-1
Source: 0001493152-25-006068
Chunk: 184

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: S-1
Chunk 184
---
 to be a new registration statement relating to the securities offered therein, and the offering of such      
 securities at that time shall be deemed to be the initial bona fide offering thereof.                                                  |
| (c) | Insofar                                                                                                                                
 as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons    
 of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the       
 Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, 
 unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of     
 expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,      
 suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,    
 the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court      
 of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities    
 Act and will be governed by the final adjudication of such issue.                                                                      |

| II-5 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of New York, NY, on the 12 thday of February, 2025.

| INDAPTUS           
 THERAPEUTICS, INC. |                    |
| By:                | /s/                
 Jeffrey A. Meckler |
| Name:              | Jeffrey            
 A. Meckler         |
| Title:             | Chief              
 Executive Officer  |

<div align='center'>POWER OF ATTORNEY</div>

KNOW ALL MEN BY THESE PRESENTED, that each director and officer of Indaptus Therapeutics, Inc., whose signature appears below hereby appoints Jeffrey A. Meckler and Nir Sassi, and each of them severally, his or her true and lawful attorneys-in-fact and agents with full powers of substitution, for him and in his name, place and stead, in any and all capacities,